Identification of retinol dehydrogenase 10 as a shared biomarker for metabolic dysfunction-associated steatotic liver disease and type 2 diabetes mellitus
BackgroundMetabolic dysfunction-associated steatotic liver disease (MASLD) is an independent risk factor for type 2 diabetes mellitus (T2DM), and its early identification and intervention offer opportunities for reversing diabetes mellitus.MethodsIn this study, we identified biomarkers for the MASLD...
Saved in:
| Main Authors: | Fangyu Li, Rui Li, Hongjun Deng |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-01-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1521416/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Alcohol Dehydrogenase 4‐Mediated Retinol Metabolism Inhibits Hepatocellular Carcinoma Progression Through Inhibiting the Wnt/β‐Catenin Pathway
by: Jiaying Li, et al.
Published: (2025-06-01) -
A Study Comparing 0.025% Topical Tretinoin Versus 4% Retinol Peel and 10% Retinol Peel in the Management of Acanthosis Nigricans
by: Shreya Srinivasan, et al.
Published: (2025-05-01) -
Ginsenoside CK and retinol on UVA-induced photoaging exert the synergistic effect through antioxidant and antiapoptotic mechanisms
by: Jingyin Zhang, et al.
Published: (2025-05-01) -
Glycemic variability in type 2 diabetic patients with metabolic dysfunction-associated steatotic liver disease: a case-control study
by: Yueqiu Wang, et al.
Published: (2025-12-01) -
Serum retinol concentration in patients with acute falciparum malaria
by: Adil Raza, et al.
Published: (2009-12-01)